{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:27:52Z","timestamp":1789756072665,"version":"4.0.1"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2019.00356","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T04:12:25Z","timestamp":1578629545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury"],"prefix":"10.3389","volume":"7","author":[{"given":"Miaad","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tweedie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Shlobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vardit","family":"Rubovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis B.","family":"Tovar-y-Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"DiMarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.11.021","article-title":"GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality.","volume":"65","author":"Anderberg","year":"2016","journal-title":"Psychoneuroendocrino"},{"key":"B2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","article-title":"Protective effects of the GLP-1 mimetic exendin-4 in Parkinson\u2019s disease.","volume":"136","author":"Athauda","year":"2018","journal-title":"Neuropharmacology"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.4304","article-title":"Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with parkinson disease: a secondary analysis of the exenatide-PD trial.","author":"Athauda","year":"2019","journal-title":"JAMA Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial.","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2009.04.064","article-title":"Deficits in ERK and CREB activation in the hippocampus after traumatic brain injury.","volume":"459","author":"Atkins","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B6","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson\u2019s disease.","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.nbd.2018.11.023","article-title":"Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.","volume":"124","author":"Bader","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP.","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/neu.2009.0891","article-title":"The influence of alcohol on behavioral recovery after mTBI in mice.","volume":"27","author":"Baratz","year":"2010","journal-title":"J. Neuro."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0237-4","article-title":"Transiently lowering tumor necrosis factor-alpha synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice.","volume":"12","author":"Baratz","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s11011-017-0059-4","article-title":"Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation.","volume":"32","author":"Barreto-Vianna","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease.","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0166-4328(01)00291-1","article-title":"Measuring normal and pathological anxiety-like behaviour in mice: a review.","volume":"125","author":"Belzung","year":"2001","journal-title":"Behav. Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease.","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s10.3.x","article-title":"The epidemiology of traumatic brain injury: a review.","volume":"44","author":"Bruns","year":"2003","journal-title":"Epilepsia"},{"key":"B16","year":"2005","journal-title":"Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers, U.S. Food and Drug Administration (Rockville, MD, USA)."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045763","article-title":"Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K\/Akt signaling after experimental traumatic brain injury.","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-016-0573-9","article-title":"The pathophysiology of concussion.","volume":"20","author":"Choe","year":"2016","journal-title":"Curr. Pain Headache Rep."},{"key":"B19","first-page":"84","article-title":"\u201cTraumatic brain injury epidemiology and public health issues,\u201d","author":"Coronado","year":"2012","journal-title":"Brain Injury Medicine: Principles and Practice"},{"key":"B20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1447-073x.2004.00089.x","article-title":"Involvement of cAMP in neuronal survival and axonal regeneration.","volume":"79","author":"Cui","year":"2004","journal-title":"Anat. Sci. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.pmr.2011.08.009","article-title":"Long-term consequences: effects on normal development profile after concussion.","volume":"22","author":"Daneshvar","year":"2011","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"B22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0166-4328(98)00079-5","article-title":"Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition.","volume":"99","author":"Dix","year":"1999","journal-title":"Behav. Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1210\/me.2002-0306","article-title":"Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.","volume":"17","author":"Drucker","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00213-010-2098-y","article-title":"The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).","volume":"214","author":"Edut","year":"2011","journal-title":"Psychopharmacology"},{"key":"B26","article-title":"Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer s disease - protocol for a controlled, randomized double-blinded trial.","volume":"59","author":"Egefjord","year":"2012","journal-title":"Dan. Med. J."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt174","article-title":"Neuroprotective effects of D-Ala(2)GIP on Alzheimer\u2019s disease biomarkers in an APP\/PS1 mouse model.","volume":"5","author":"Faivre","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"B28","doi-asserted-by":"crossref","first-page":"A268","DOI":"10.1136\/ip.2010.029215.951","article-title":"Traumatic brain injury in the United States: national estimates of prevalence and incidence, 2002\u20132006.","volume":"16","author":"Faul","year":"2010","journal-title":"Inj. Prev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.peptides.2010.12.010","article-title":"Glucose-dependent insulinotropic peptide receptor expression in the hippocampus and neocortex of mesial temporal lobe epilepsy patients and rats undergoing pilocarpine induced status epilepticus.","volume":"32","author":"Figueiredo","year":"2011","journal-title":"Peptides"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195179484.001.0001","author":"Finkelstein","year":"2006","journal-title":"The Incidence and Economic Burden of Injuries in the United States."},{"key":"B32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","article-title":"Head injury as a risk factor for Alzheimer\u2019s disease: the evidence 10 years on; a partial replication.","volume":"74","author":"Fleminger","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.07.011","article-title":"The sustained effects of a dual GIP\/GLP-1 receptor agonist, NNC0090-2746, in patients with Type 2 diabetes.","volume":"26","author":"Frias","year":"2017","journal-title":"Cell Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jss.2016.07.014","article-title":"Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K\/AKT pathways as a potential mechanism.","volume":"206","author":"Gao","year":"2016","journal-title":"J. Surg. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","article-title":"Epidemiology of mild traumatic brain injury and neurodegenerative disease.","volume":"66","author":"Gardner","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s Disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial.","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1021\/acsptsci.9b00003","article-title":"Incretin mimetics as rational candidates for the treatment of traumatic brain injury.","volume":"2","author":"Glotfelty","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/msj.20104","article-title":"Pathophysiology of traumatic brain injury.","volume":"76","author":"Greve","year":"2009","journal-title":"Mt. Sinai J. Med."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00500","article-title":"Plant polyphenols and exendin-4 prevent hyperactivity and TNF-\u03b1 release in LPS-treated in vitro neuron\/astrocyte\/microglial networks.","volume":"11","author":"Gullo","year":"2017","journal-title":"Front. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/WNR.0000000000000490","article-title":"A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat.","volume":"27","author":"Han","year":"2016","journal-title":"Neuroreport"},{"key":"B42","doi-asserted-by":"publisher","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.","volume":"221","author":"Holscher","year":"2014","journal-title":"J. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neurobiolaging.2008.08.023","article-title":"New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer\u2019s disease?","volume":"31","author":"Holscher","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.246","article-title":"Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review.","volume":"23","author":"Hopperton","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jnr.22596","article-title":"Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia.","volume":"89","author":"Hyun Lee","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1089\/neu.2008-0676","article-title":"Closed head injury in a mouse model results in molecular changes indicating inflammatory responses.","volume":"26","author":"Israelsson","year":"2009","journal-title":"J. Neuro."},{"key":"B48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1 beta production in cultured rat astrocytes.","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity.","volume":"9","author":"Kappe","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/0963689717721234","article-title":"A new treatment strategy for Parkinson\u2019s disease through the gut-brain Axis: the glucagon-like peptide-1 receptor pathway.","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Transpl."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson\u2019s disease.","volume":"202","author":"Kim","year":"2009","journal-title":"J. Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(15)00002-2","article-title":"Diagnosis, prognosis, and clinical management of mild traumatic brain injury.","volume":"14","author":"Levin","year":"2015","journal-title":"Lancet Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/jnc.13169","article-title":"Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.","volume":"135","author":"Li","year":"2015","journal-title":"J. Neurochem."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032008","article-title":"Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1074\/jbc.m209423200","article-title":"Glucagon-like peptide-1 receptor signaling modulates \u03b2 cell apoptosis.","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuropharm.2015.10.002","article-title":"Neuroprotective effects of a GIP analogue in the MPTP Parkinson\u2019s disease mouse model.","volume":"101","author":"Li","year":"2016","journal-title":"Neuropharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.","volume":"113","author":"Li","year":"","journal-title":"J. Neurochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer\u2019s disease.","volume":"19","author":"Li","year":"","journal-title":"J. Alzheimers. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia.","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus.","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults.","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease.","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes Metab. Res. Rev"},{"key":"B64","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease.","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i6.807","article-title":"Central functions of glucagon-like peptide-1: roles in energy regulation and neuroprotection.","volume":"6","author":"McGrath","year":"2015","journal-title":"J. Steroids Horm Sci."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174847","article-title":"Mild Traumatic Brain Injury (mTBI) and chronic cognitive impairment: a scoping review.","volume":"12","author":"McInnes","year":"2017","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/neu.2005.22.1003","article-title":"Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice.","volume":"22","author":"Milman","year":"2005","journal-title":"J. Neurotrauma"},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/aem128","article-title":"Traumatic brain injury: assessment, resuscitation and early management.","volume":"99","author":"Moppett","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"B69","year":"2016","journal-title":"Data From the National Health and Nutrition Examination Survey; Anthropometric Reference Data for Children and Adults: United States, 2011\u20132014. DHHS Publication No. 2016\u20131604 (Hyattsville, MD, USA)."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1523\/jneurosci.4920-04.2005","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.","volume":"25","author":"Nyberg","year":"2005","journal-title":"J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/187152411798047771","article-title":"Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival.","volume":"11","author":"Paratore","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2012.00058","article-title":"Understanding the neuroinflammatory response following concussion to develop treatment strategies.","volume":"6","author":"Patterson","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/s0165-6147(03)00160-3","article-title":"The glucagon-like peptides: a double-edged therapeutic sword?","volume":"24","author":"Perry","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.","volume":"203","author":"Perry","year":"2007","journal-title":"Exp. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/dom.13025","article-title":"Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide\/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects.","volume":"19","author":"Portron","year":"2017","journal-title":"Diabetes. Obes. Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s11357-012-9464-0","article-title":"Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.","volume":"35","author":"Rachmany","year":"2013","journal-title":"Age"},{"key":"B78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.nbd.2010.01.021","article-title":"The intricate involvement of the Insulin-like growth factor receptor signaling in mild traumatic brain injury in mice.","volume":"38","author":"Rubovitch","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/dom.13024","article-title":"Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide\/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus.","volume":"19","author":"Schmitt","year":"2017","journal-title":"Diabetes. Obes. Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences.","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Invest."},{"key":"B82","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopha.2017.08.125","article-title":"Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K\/Akt\/mTOR signaling pathway in rats with traumatic brain injury.","volume":"95","author":"Shen","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbr.2017.03.032","article-title":"A novel dual GLP-1\/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.","volume":"327","author":"Shi","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejcb.2017.03.004","article-title":"Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.","volume":"96","author":"Spielman","year":"2017","journal-title":"Eur. J. Cell Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"35920","DOI":"10.1074\/jbc.m204784200","article-title":"Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I.","volume":"277","author":"Tabuchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00701-005-0651-y","article-title":"A systematic review of brain injury epidemiology in Europe.","volume":"148","author":"Tagliaferri","year":"2006","journal-title":"Acta Neurochir."},{"key":"B87","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.expneurol.2016.11.005","article-title":"Novel GLP-1R\/GIPR co-agonist \u201ctwincretin\u201d is neuroprotective in cell and rodent models of mild traumatic brain injury.","volume":"288","author":"Tamargo","year":"2017","journal-title":"Exp. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.brainres.2006.10.032","article-title":"Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice.","volume":"1130","author":"Tashlykov","year":"2007","journal-title":"Brain Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1210\/mend.15.9.0688","article-title":"Glucose-dependent insulinotropic polypeptide is a growth factor for \u03b2 (INS-1) cells by pleiotropic signaling.","volume":"15","author":"Tr\u00fcmper","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jalz.2015.07.489","article-title":"Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.","volume":"12","author":"Tweedie","year":"","journal-title":"Alzheimers Dement"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jneumeth.2016.02.003","article-title":"Mild traumatic brain injury-induced hippocampal gene expressions: the identification of target cellular processes for drug development.","volume":"272","author":"Tweedie","year":"","journal-title":"J. Neurosci. Methods"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.02.006","article-title":"Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.","volume":"54","author":"Tweedie","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/14728222.2018.1487952","article-title":"Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.","volume":"22","author":"Verma","year":"2018","journal-title":"Expert. Opin. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2017.03.059","article-title":"Effect of D-Ala(2)GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice.","volume":"804","author":"Verma","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1080\/02699052.2018.1537513","article-title":"Aminoguanidine reverses cognitive deficits and activation of cAMP\/CREB\/BDNF pathway in mouse hippocampus after traumatic brain injury (TBI).","volume":"32","author":"Wang","year":"2018","journal-title":"Brain Inj."},{"key":"B96","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bbrc.2016.11.138","article-title":"Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K\/Akt pathway in rats with traumatic brain injury.","volume":"482","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1089\/neu.2012.2456","article-title":"The effect of injury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate, and severe controlled cortical impact injury in mice.","volume":"29","author":"Washington","year":"2012","journal-title":"J. Neurotraum."},{"key":"B98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury.","volume":"99","author":"Werner","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"B99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.12.005","article-title":"Both classic Gs- cAMP\/PKA\/CREB and alternative Gs-cAMP\/PKA\/p38\u03b2\/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers.","volume":"316","author":"Wu","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1089\/neu.2015.4229","article-title":"Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats.","volume":"33","author":"Yu","year":"2016","journal-title":"J. Neurotrauma"},{"key":"B101","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejphar.2017.06.029","article-title":"A novel GLP-1\/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson\u2019s disease.","volume":"812","author":"Yuan","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease.","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"B103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.55782\/ane-2011-1821","article-title":"Behavioral consequences of minimal traumatic brain injury in mice.","volume":"71","author":"Zohar","year":"2011","journal-title":"Acta Neurobiol. Exp."},{"key":"B104","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/s0306-4522(03)00048-4","article-title":"Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice.","volume":"118","author":"Zohar","year":"2003","journal-title":"Neuroscience"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2019.00356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T23:06:32Z","timestamp":1722294392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2019.00356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":104,"alternative-id":["10.3389\/fcell.2019.00356"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2019.00356","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"article-number":"356"}}